New in vivo preclinical data announced today, demonstrate that icovamenib, in combination with semaglutide showed additional 11.5% body weight reduction and 43% increase in lean muscle mass compared ...
Marshall Health Network is proud to offer the following community events and screenings for the beginning of January. Don't miss out on these opportunities to connect and get the latest information, ...